# ğŸ§‘â€ğŸ’» **Recovery Kernel â€” JRTokenâ€‘NGI**  
### *Openâ€‘source neurogenomics meets humanâ€‘first recovery engineering.*

Welcome to the **Recovery Kernel**, a forkâ€‘friendly, globally accessible framework that reverseâ€‘engineers addiction through systems thinking, neurogenomics, and unapologetically open knowledge. Built for hackers, researchers, clinicians, and anyone who believes human resilience should scale like good infrastructure.

This isnâ€™t a selfâ€‘help book.  
This is a **protocol stack for understanding biological vulnerability** â€” translated into multiple languages, structured like a technical spec, and released under a license that says:  
**â€œTake it, break it, fork it, improve it.â€**

---

## ğŸš€ **Why This Exists**
Because:
- biology shouldnâ€™t be proprietary  
- recovery shouldnâ€™t be paywalled  
- and public health deserves the same transparency as openâ€‘source software  

The Recovery Kernel treats addiction not as a moral failure but as a **biological bottleneck** shaped by genetics, stressâ€‘response pathways, and environmental load. No mysticism. No gatekeeping. Just structured knowledge.

---

## ğŸ§¬ **Whatâ€™s Inside**
- **Multilingual editions** of the Recovery Kernel (20+ languages)  
- **Neurogenomic sovereignty whitepapers**  
- **Publicâ€‘health toolkits**  
- **Policy briefs** for governments and institutions  
- **Genomic literacy materials**  
- **A prototype kit** for mapping neurochemical pathways  

If it helps people understand themselves better, itâ€™s in here.

---

## ğŸ—‚ï¸ **Repository Structure**
```
/kernel_v1.0        â†’ Canonical chapters + technical modules  
/localization       â†’ All translated editions  
/framework_docs     â†’ Whitepapers, handbooks, policy briefs  
/assets             â†’ Images, diagrams, supporting files  
/legacy_distros     â†’ Early drafts, fun experiments, archival curiosities  
```

---

## ğŸŒ **Who This Is For**
- engineers who like to optimize humans the way they optimize systems  
- clinicians who want clear, accessible science  
- policymakers who need structured, nonâ€‘ideological briefs  
- translators, educators, and openâ€‘knowledge advocates  
- anyone who wants to understand why their brain does what it does  

If youâ€™ve ever said â€œI rewrote the config because the defaults offended me,â€ youâ€™ll feel at home here.

---

## ğŸ¤ **Contributing**
Pull requests welcome.  
Translations welcome.  
Scientific corrections welcome.  
Pedantry welcome.  

If you can make this more accurate, more accessible, or more globally useful, fork away.

---

## ğŸ“œ **License**
**CC0â€‘1.0** â€” Public Domain.  
No paywalls. No restrictions. No corporate nonsense.  
Just knowledge.

---

## ğŸŒ **Project Link**
https://archive.org/details/the-recovery-kernel

## Major Substance Classes & Groups

Opioids (primary focus; many CYP2D6/CYP3A4/OPRM1 correlations)
Depressants / CNS Depressants
Stimulants
Psychedelics / Classic Hallucinogens
Entactogens / Empathogens
New Psychoactive Substances (NPS)
Plant-based / Botanical substances
Polypharmacy combinations (analyzed for dangerous interactions)

Specific Substances Covered

Alcohol (ethanol) â€” GABRA2 variants, impulsivity correlation
Opioids (general class)
Heroin
Fentanyl
Codeine
Tramadol
Oxycodone
Hydrocodone
Morphine

Stimulants
Cocaine
Methamphetamine (meth)
Amphetamines (general)
Caffeine (CYP1A2 slow metabolizers)

MDMA (Ecstasy/Molly) â€” Serotonin depletion, "Suicide Tuesday" crash, interaction warnings (e.g., + Lithium)
Ketamine â€” In deadly combo warning (E+K=G=NEVER)
GHB (Gamma-Hydroxybutyrate) â€” In deadly combo warning
Cannabis (Marijuana) â€” CNR1/FAAH genes, paranoia/psychosis risk
Psilocybin (Magic mushrooms) â€” HTR2A correlations
LSD (Lysergic acid diethylamide) â€” Anxiety/psychosis risk
DMT (Dimethyltryptamine) â€” MAOA low activity, prolonged effects
Kratom â€” CYP2D6/3A4 inhibition, drug-drug interactions (DDIs), dependence potential
Kava â€” Hepatotoxicity risk, often combined (e.g., in products like Feel Free)
Benzodiazepines (general; implied in depressant stacking)
Barbiturates (historical/reference in polypharmacy cases)
Caffeine (as stimulant, CYP1A2 relevance)
Nicotine / Tobacco (implied in broader stimulant/depressant contexts)

Notable Combinations & Special Cases Analyzed

MDMA + Ketamine + GHB (fatal "E+K=G" warning)
Lithium + MDMA (serotonin syndrome + brain damage)
Polypharmacy in celebrity cases (e.g., Prince: fentanyl; Elvis: tolerance reset failure; Marilyn Monroe: likely CYP2D6/2C19 issues with multiple drugs)

